The analysis of the permeability process of calcium antagonists in developing transdermal forms with a cardiovascular effect


	Amlodipine 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester.

Part of: Shyteyeva T, Gubar S, Smielova N, Bezchasnyuk E, Budanova L (2021) The analysis of the permeability process of calcium antagonists in developing transdermal forms with a cardiovascular effect. Pharmacia 68(1): 189-193. https://doi.org/10.3897/pharmacia.68.e37632